What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity.
作者信息
Hejal Rana, Popa Andrea, Rangel Maribel Llamas, Remy Kenneth E
机构信息
Department of Medicine, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Ohio, USA.
Department of Pharmacy, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
出版信息
Int J Crit Illn Inj Sci. 2023 Apr-Jun;13(2):45-47. doi: 10.4103/ijciis.ijciis_25_23. Epub 2023 Jun 26.
Abstract
摘要
相似文献
1
What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity.危重病与损伤科学有哪些新进展？权衡肥胖重症患者右美托咪定给药的证据。
Int J Crit Illn Inj Sci. 2023 Apr-Jun;13(2):45-47. doi: 10.4103/ijciis.ijciis_25_23. Epub 2023 Jun 26.
2
What's New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium.危重病与损伤科学有哪些新进展？使用S100β诊断和对患有谵妄的危重病患者进行风险分层的证据与局限性。
Int J Crit Illn Inj Sci. 2023 Jul-Sep;13(3):83-84. doi: 10.4103/ijciis.ijciis_51_23. Epub 2023 Sep 21.
3
Evaluation of Dexmedetomidine Dosing in Obese Critically Ill Patients.肥胖重症患者右美托咪定给药剂量的评估
J Pharm Pract. 2023 Feb;36(1):67-73. doi: 10.1177/08971900211021578. Epub 2021 Jun 10.
4
Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.危重症肥胖患者的药物剂量调整——关注镇静、镇痛和谵妄。
Crit Care. 2020 Jun 8;24(1):315. doi: 10.1186/s13054-020-03040-z.
5
Protein Binding and Population Pharmacokinetics of Dexmedetomidine after Prolonged Infusions in Adult Critically Ill Patients.蛋白结合与成人危重症患者长时间输注右美托咪定后的群体药代动力学。
Clin Ther. 2021 Aug;43(8):1356-1369.e1. doi: 10.1016/j.clinthera.2021.06.004. Epub 2021 Jul 23.
6
Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients.对一组神经损伤肥胖重症患者中右美托咪定给药情况的回顾性评估。
Int J Crit Illn Inj Sci. 2023 Apr-Jun;13(2):48-53. doi: 10.4103/ijciis.ijciis_74_22. Epub 2023 Jun 26.
7
Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.α2 激动剂用于危重症患者机械通气期间的长期镇静。
Cochrane Database Syst Rev. 2015 Jan 6;1(1):CD010269. doi: 10.1002/14651858.CD010269.pub2.
8
Dexmedetomidine for the prevention of delirium in critically ill patients - A protocol for a systematic review.右美托咪定预防危重症患者谵妄的系统评价方案。
Acta Anaesthesiol Scand. 2019 Apr;63(4):540-548. doi: 10.1111/aas.13313. Epub 2019 Jan 23.
9
Dexmedetomidine for the management of delirium in critically ill patients-A protocol for a systematic review.右美托咪定在危重症患者谵妄管理中的应用：系统评价方案。
Acta Anaesthesiol Scand. 2019 Apr;63(4):549-557. doi: 10.1111/aas.13329. Epub 2019 Jan 31.
10
Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.在成年危重症患者中长时间输注镇静和镇痛药物时的药代动力学改变：系统评价。
Clin Ther. 2018 Sep;40(9):1598-1615.e2. doi: 10.1016/j.clinthera.2018.07.021. Epub 2018 Aug 31.
本文引用的文献
1
Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients.对一组神经损伤肥胖重症患者中右美托咪定给药情况的回顾性评估。
Int J Crit Illn Inj Sci. 2023 Apr-Jun;13(2):48-53. doi: 10.4103/ijciis.ijciis_74_22. Epub 2023 Jun 26.
2
Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials.右美托咪定与其他镇静剂在危重症机械通气成人中的比较：随机试验的系统评价和荟萃分析。
Intensive Care Med. 2022 Jul;48(7):811-840. doi: 10.1007/s00134-022-06712-2. Epub 2022 Jun 1.
3
Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.成人 ICU 患者疼痛、躁动/镇静、谵妄、活动减少、睡眠障碍预防与管理临床实践指南。
Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299.
4
Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.低剂量右美托咪定预防 ICU 谵妄：一项随机、安慰剂对照试验。
Am J Respir Crit Care Med. 2018 May 1;197(9):1147-1156. doi: 10.1164/rccm.201710-1995OC.
5
Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery.静脉注射右美托咪定在接受腹腔镜手术的病态肥胖患者中的药代动力学和药效学
J Anesth. 2017 Dec;31(6):813-820. doi: 10.1007/s00540-017-2399-y. Epub 2017 Aug 21.
6
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.右美托咪定的临床药代动力学与药效学
Clin Pharmacokinet. 2017 Aug;56(8):893-913. doi: 10.1007/s40262-017-0507-7.
7
Role of Dexmedetomidine for Sedation in Neurocritical Care Patients: A Qualitative Systematic Review and Meta-analysis of Current Evidence.右美托咪定在神经重症监护患者镇静中的作用：当前证据的定性系统评价和荟萃分析
Clin Neuropharmacol. 2016 May-Jun;39(3):144-51. doi: 10.1097/WNF.0000000000000151.
8
Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial.右美托咪定联合标准治疗对躁动谵妄患者呼吸机使用时间的影响：一项随机临床试验。
JAMA. 2016 Apr 12;315(14):1460-8. doi: 10.1001/jama.2016.2707.
9
Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials.重症监护患者中右美托咪定镇静的疗效和安全性：一项随机对照试验的荟萃分析。
Anaesth Crit Care Pain Med. 2016 Feb;35(1):7-15. doi: 10.1016/j.accpm.2015.06.012. Epub 2015 Dec 11.
10
Population pharmacokinetics of dexmedetomidine in critically ill patients.危重症患者右美托咪定的群体药代动力学。
Clin Drug Investig. 2013 Aug;33(8):579-87. doi: 10.1007/s40261-013-0101-1.
Zotero 插件